Join
Live feed
·
INSIDERFilingvia Quantisnow
Verona Pharma plc logo

Director Cunningham Kenneth converted options into 24,000 units of Ordinary Shares and sold $142,057 worth of Ordinary Shares (10,808 units at $13.14), increasing direct ownership by 20% to 79,776 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VRNA (Verona Pharma plc) and more on Quantisnow.